Drug Database
Back to search

Netherlands· NL-9e667664b6e5

Tranxène 20 MB, omhulde tabletten 20 mg

A potassium clorazepate product containing clorazepaat dikalium, registered in Netherlands by Neuraxpharm Netherlands B.V.. The same ATC class is registered in 7 of our 19 countries.

ATC N05BA05

Checked against CBG-MEB (Netherlands) on

Informational only — not a medical device.

SOURCE REGISTER · NLCBG-MEB (Netherlands)normalisedTranxène 20 MB, omhulde tabletten 20 …ATCN05BA05REGISTER NO.NL-9e667664b6e5PACKS LISTED1CHECKEDSeptember 29, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about clorazepaat dikaliumAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Potassium clorazepate is registered in 7 of 19 countries.

Countries holding a registration under ATC N05BA05 (potassium clorazepate), each read from that country’s own register.

  • This record: Netherlands, from CBG-MEB (Netherlands)
  • 4 of them publish a price we can compare per daily dose
Search potassium clorazepate products by name

Potassium clorazepate · ATC N05BA05

7 / 19 countries

  • Belgiumprice
  • Canada
  • Finlandprice
  • Japan
  • Netherlands
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of potassium clorazepate costs, country by country.

Normalised to the WHO defined daily dose (20 mg), so markets compare like for like.

  • 1 market with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown
Open the full comparison — free accountDrug prices for market access

Potassium clorazepate · price per daily dose (20 mg)

USD · FX 28 Sept 2026

  • CH Switzerland$0.83
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

CBG-MEB (Netherlands)
Active substance
CLORAZEPAAT DIKALIUM
Manufacturer
Neuraxpharm Netherlands B.V.
Country
Netherlands (NL)
ATC code
N05BA05
ATC class
Potassium clorazepate
Defined daily dose
20 mg, O
Reimbursed
Not published by this register
Source register
CBG-MEB (Netherlands)
Last checked
September 29, 2026

Packs & prices · 1

  • cbg_meb_id
    16979

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

192 interactions on record for potassium clorazepate.

Graded by severity as the source publishes them — 4 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check potassium clorazepate against other medicinesHow interaction checks work

Potassium clorazepate · interactions on record

192 records

  • 4 severe
  • 117 moderate
  • 22 minor

Most severe, free to view

  • MorphineN02AA01severe
  • MorphinN07BC09severe
  • HydrocodoneR05DA03severe
  • CodeineR05DA04severe

49 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Potassium clorazepate in 3 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All potassium clorazepate products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/84718dc9-0862-4eba-b1c2-4f3a2b8b1914
GET /v1/drugs/84718dc9-0862-4eba-b1c2-4f3a2b8b1914?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Filmomhulde tablet",
  "route": "Oraal gebruik",
  "soort": "RVG",
  "source": "cbg_meb",
  "smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h16979_smpc.pdf",
  "strength": null,
  "atc_label": "Potassium Clorazepate",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg16979",
  "excipients": [
    "BASISCH GEBUTYLEERD METHACRYLAAT COPOLYMEER (E 1205)",
    "CASTOROLIE, GEHYDROGENEERD",
    "CELLULOSE, MICROKRISTALLIJN (E 460(i))",
    "COPOLYMEER VAN METHACRYLAAT KALIUM-DIVINYLBENZEEN",
    "DIETHYLFTALAAT",
    "INDIGOKARMIJN ALUMINIUMLAK (E 132)",
    "KALIUMCARBONAAT 0-WATER (E 501)",
    "LACTOSE 0-WATER",
    "MAGNESIUMSTEARAAT (E 470b)",
    "TALK (E 553b)",
    "TITAANDIOXIDE (E 171)"
  ],
  "substances": [
    "CLORAZEPAAT DIKALIUM"
  ],
  "leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h16979.pdf",
  "authorised_at": "1995/02/27",
  "procedure_number": null,
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "16979",
  "additional_monitoring": "N"
}
API referenceMCP serverPlans

See everything about potassium clorazepate.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console